The latest wellness craze involves injecting these molecules for athletic performance, longevity and more. Scientists say the research isn't keeping pace with the health claims.
Researchers at the Ribeirao Preto Blood Center and the Center for Cell-Based Therapy (CTC) conducted a study using the NK-92 ...
BACKGROUND: The entrance of naive T cells into lymph nodes (LNs) is a crucial step for induction of heart transplant acceptance under costimulatory blockade. Specialized blood vessels within the LN ...
The difficulty is that EBV lives latently in B cells in the blood at a frequency, in most immunocompetent individuals, of about 1 in 100,000 to 1 in a million. That level of infection is below the ...
Doctors at Boston’s Beth Israel share how CAR T cell therapy and other emerging immune therapies are delivering promising ...
In the rapidly moving field, questions remain regarding long-term safety, durability of remission, and the FDA’s approach to ...
Researchers from Tr1x Inc. presented the development of TRX-319, a novel allogeneic regulatory T-cell therapy designed for the treatment of autoimmune disorders.
In this prospective cohort study, CD19-directed chimeric antigen receptor (CAR) T-cell therapy was found to elicit a complete response in eleven patients with autoimmune hemolytic anemia who had ...
RNA CAR T therapy Descartes‑08 targets BCMA‑positive plasma cells and delivers year‑long symptom relief in myasthenia gravis after a brief course, signaling a new era of durable treatment.
NEW YORK – An autologous CAR T-cell therapy has shown promise treating a rare autoimmune disease known as autoimmune hemolytic anemia (AIHA), and plans for evaluations in larger clinical trials are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results